NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018

Robert I. Haddad(Georgetown University), Lisa A. Gurski(National Comprehensive Cancer Network), Rebecca S. Sippel(University of Wisconsin–Madison), Andrei Iagaru(Stanford University), K Hoffmann(Leipzig University of Applied Sciences), Cord Sturgeon(Northwestern University), Lori J. Wirth(Massachusetts General Hospital), Whitney Goldner(University of Nebraska Medical Center), Jatin P. Shah(Memorial Sloan Kettering Cancer Center), Megan R. Haymart(University of Michigan), Paxton V. Dickson(University of Tennessee Health Science Center), Naifa L. Busaidy(The University of Texas MD Anderson Cancer Center), Carl K. Hoh(UC San Diego Health System), Bryan McIver, John A. Ridge(Fox Chase Cancer Center), Peter Kopp(Northwestern University), Alyse Johnson-Chilla(National Comprehensive Cancer Network), Glenda G. Callender(Yale Cancer Center), Matthew D. Ringel(The Ohio State University Wexner Medical Center), Christian Nasr(Cleveland Clinic), Richard J. Wong(Memorial Sloan Kettering Cancer Center), Randall P. Scheri(Duke University), Christopher D. Raeburn(University of Colorado Anschutz Medical Campus), Quan‐Yang Duh(UCSF Helen Diller Family Comprehensive Cancer Center), Robert C. Smallridge(Nemours Children's Clinic), David R. Byrd(University of Washington), Hormoz Ehya(Fox Chase Cancer Center), Jason P. Hunt(University of Utah), Fouad Kandeel(City of Hope), Lindsay Bischoff(Breast Cancer Research Foundation), Dominick Lamonica(Dana-Farber Brigham Cancer Center)
Journal of the National Comprehensive Cancer Network
December 1, 2018
Cited by 370


Related Papers